Weiguang Zhang | Molecular Biology | Best Researcher Award

Prof. Weiguang Zhang | Molecular Biology | Best Researcher Award 

Prof. Weiguang Zhang, Peking university, China

Prof. Weiguang Zhang, a distinguished professor at Peking University Health Science Center, is a leading expert in human anatomy, vascular structure, and lipid metabolism. Serving as the Director of the Medical Library and Executive Deputy Director of the Department of Human Anatomy and Histology, he integrates AI into medical education and leads numerous national-level research and teaching projects. With over 70 high-impact publications, a patent, and key editorial and professional roles, Prof. Zhang is widely recognized for his academic excellence, innovation, and leadership in anatomical sciences and medical library development.

Author profile

Orcid

🎓 Early Academic Pursuits

Prof. Weiguang Zhang embarked on his academic journey with a profound interest in the structure and function of the human body. His early education was rooted in rigorous medical sciences, where he showed a particular affinity for anatomy, histology, and embryology. His foundational years were marked by an exceptional ability to merge classical anatomical knowledge with evolving medical technology.

It was during this formative period that Prof. Zhang recognized the transformative potential of technology in anatomical education, which would later define much of his academic legacy. He honed his expertise through advanced degrees and research engagements that laid the groundwork for his groundbreaking work in vascular anatomy and lipid metabolism of the liver and brain.

👨‍⚕️ Professional Endeavors

Prof. Zhang currently serves as Professor and Doctoral Supervisor in the Department of Human Anatomy, Histology, and Embryology at the School of Basic Medical Sciences, Peking University Health Science Center. He is also the Director of the Medical Library of Peking University and the Executive Deputy Director of his department — roles that showcase his versatile leadership across education, research, and institutional development.

With a deep-seated commitment to academic excellence, he has successfully led and managed over 20 major teaching and research projects, many of which received national and municipal-level recognition. His passion for teaching extends beyond the classroom—Prof. Zhang is a dedicated mentor to more than 20 doctoral and master’s students, and has supervised over 100 undergraduate innovators in research and innovation.

He has also played an instrumental role in establishing the Brain Bank, a significant initiative that facilitates neurological research and post-mortem anatomical studies for scientific and educational advancement.

🔬 Contributions and Research Focus

Prof. Zhang’s primary research interests lie in the vascular architecture and lipid metabolism of the liver and brain — critical areas in understanding neurovascular diseases, fatty liver disorders, and related systemic pathologies. His studies have advanced knowledge in microvascular anatomy, hepatic circulation, and cerebral lipid transport, contributing significantly to translational medicine.

In addition to his research in anatomy, Prof. Zhang is a pioneer in applying artificial intelligence (AI) to medical education, particularly in human anatomy teaching. He has developed AI-integrated pedagogical models that enhance visualization and interactivity in anatomical learning — a substantial shift from traditional methods.

His scholarly output includes:

  • 70+ SCI/Scopus-indexed publications

  • 10 major consultancy and industry collaborations

  • Authorship of books and textbooks, including one with ISBN: 978-7-5659-3126-0

  • A patent (CN 118001408) related to his core research areas

Prof. Zhang’s editorial influence is evident in his role as Deputy Editor-in-Chief of the Journal of Anatomy, where he helps shape the future of scholarly discourse in anatomical sciences.

🏅 Accolades and Recognition

Prof. Zhang’s contributions have earned him numerous accolades, including:

  • National Curriculum Ideology & Politics Teaching Expert

  • Beijing Distinguished Teaching Award

  • Peking University Teaching Excellence Award

His commitment to teaching innovation and research leadership has established him as a trusted authority both nationally and internationally. He also holds the position of Deputy Secretary-General of the Chinese Anatomical Society, further amplifying his voice in national anatomical policy and curriculum development.

🌍 Impact and Influence

Prof. Zhang’s influence extends well beyond the academic sphere. His work in intelligent medical library development has revolutionized access to medical resources, supporting students, researchers, and clinicians across China. As a multifaceted educator, his blending of AI and anatomical science serves as a model for modern medical instruction in the 21st century.

Through his role in the Brain Bank initiative, he provides an invaluable infrastructure for research into neurodegenerative diseases, brain injuries, and more — cementing his reputation as a key contributor to both medical science and public health advancement.

His interdisciplinary impact resonates in:

  • Medical curriculum reform

  • Digital transformation in education

  • Cross-institutional and global research collaborations

🌟 Legacy and Future Contributions

Prof. Zhang’s career is a remarkable blend of tradition and transformation. He preserves the rich legacy of classical anatomical science while trailblazing into future-forward domains such as AI-based teaching and data-driven research. His mentorship of a new generation of scientists ensures that his innovative spirit and scholarly integrity will continue to shape the field long into the future.

Looking ahead, Prof. Zhang aims to:

  • Expand AI applications in medical simulation

  • Strengthen international anatomical research networks

  • Develop open-access resources through his leadership in the medical library domain

  • Drive policy changes to integrate tech-enhanced learning into national curricula

✍️Publication Top Notes


📘 Th2 cells infiltrating high-grade serous ovarian cancer: a feature that may account for the poor prognosis

ContributorsHao Su; Yueqi Jin; Changyu Tao; Hua Yang; Ence Yang; Wei-Guang Zhang; Fengzhi Feng
Journal: Gynecologic Oncology
Year: 2023

📘 Dihydromyricetin Alleviates Ischemic Brain Injury by Antagonizing Pyroptosis in Rats

Contributors: Huiru Ding; Quancheng Cheng; Xuan Fang; Ziyuan Wang; Jinyu Fang; Huaicun Liu; Junwei Zhang; Chunhua Chen; Weiguang Zhang
Journal: Neurotherapeutics
Year: 2023

📘Percutaneous Release of the First Extensor Tendon Compartment in De Quervain’s Disease by Acupotomy with US-Guidance: A Cadaveric Study

ContributorsYifeng Shen; Qiaoyin Zhou; Xiaojie Sun; Shiliang Li; Weiguang Zhang
Journal: Pain Research
Year: 2022

Soumitra Moulick | Microbiology | Best Researcher Award | 13395

Mr. Soumitra Moulick | Microbiology | Best Researcher Award

Mr. Soumitra Moulick, TCG Lifesciences Pvt. Ltd., India

Mr. Soumitra Moulick, Lead Scientist at TCG Lifesciences Pvt. Ltd., brings over 18 years of expertise in drug discovery research, with impactful contributions in antimicrobial, anti-inflammatory, and anticancer therapeutics. Currently pursuing a PhD at NIT Raipur, he has published peer-reviewed papers and is engaged in an ICMR-funded project on antibiotic-resistant E. coli. His work has supported over 15 global collaborations with pharmaceutical leaders, earning recognition including a best poster award at IIIT Allahabad. His consistent commitment to innovation and translational science underscores his suitability for the Best Researcher Award.

Profile

Scopus

🎓 Early Academic Pursuits

Mr. Soumitra Moulick embarked on his academic journey with a Master’s degree from a reputed Indian university, laying a strong foundation in life sciences and pharmacological research. From the beginning, his keen interest in drug discovery and therapeutic development drove him to pursue in-depth studies in microbiology, pharmacology, and biochemistry. His academic dedication was further demonstrated when he enrolled in a PhD program at the prestigious National Institute of Technology (NIT), Raipur, where he continues to explore advanced research in antibacterial drug discovery. His early education equipped him with a robust scientific mindset and set the stage for a dynamic career in the pharmaceutical sector.

🧪 Professional Endeavors

Mr. Moulick has devoted over 18 years of his professional life to TCG Lifesciences Pvt. Ltd., Kolkata, one of India’s leading Contract Research Organizations (CROs). Rising through the ranks, he currently serves as a Lead Scientist in the In-vitro Pharmacology Department. In this role, he has led and collaborated on more than 15 drug discovery projects, targeting diseases in the therapeutic areas of oncology, infectious diseases, and inflammation.

His work spans protocol development, in-vitro screening, target validation, and assay optimization. Mr. Moulick has worked closely with world-renowned pharmaceutical companies such as Pfizer, Roche, Takeda, Grunenthal, MMV, and DNDi, showcasing his ability to integrate scientific rigor with industry demands. His career at TCG Lifesciences stands as a testament to his commitment, technical excellence, and leadership in translational research.

🔬 Contributions and Research Focus

Mr. Moulick’s primary research interests lie in antimicrobial resistance (AMR), anti-inflammatory therapeutics, and oncology drug discovery. His doctoral research focuses on antibiotic-resistant Escherichia coli, a major causative agent of urinary tract infections. This work is supported by the Indian Council of Medical Research (ICMR) under Grant No. DDR/IIRP23/0569.

He has already published two peer-reviewed research articles in reputed journals such as Microbial Drug Resistance and Microbial Pathogenesis. Despite the limitations on publishing often faced in CRO environments, Mr. Moulick has successfully balanced industry confidentiality with academic contribution. His scientific research emphasizes innovation, with a focus on identifying novel molecular targets, validating high-throughput screening methodologies, and exploring natural and synthetic compound libraries for drug efficacy.

🏅 Accolades and Recognition

Mr. Moulick’s contributions have not gone unnoticed. His poster presentation at the International Webinar cum Workshop on Recent Developments in Applied Biotechnology (organized by IIIT Allahabad) was honored with a Best Poster Award, reflecting the academic community’s recognition of his impactful research.

One of his recent publications received a provisional selection for the “Best Researcher Award”, further validating the significance and originality of his scientific output. In addition to this, he is currently in the process of contributing a book chapter, and he has one patent under review, indicating his continued engagement in knowledge creation and technology transfer.

🌍 Impact and Influence

Over nearly two decades, Mr. Moulick has significantly influenced both industry and academic research through his extensive project experience and collaborative spirit. His ability to work with global pharmaceutical giants has not only enhanced the credibility of Indian CROs but also brought innovative therapeutic candidates closer to clinical application.

His research on antibiotic resistance has real-world implications, particularly in the context of rising multidrug-resistant infections. By identifying alternative treatment strategies and molecular targets, Mr. Moulick’s work contributes meaningfully to public health and global medicine. His influence extends across laboratories, boardrooms, and academic institutions, as he frequently engages in collaborative projects that bridge academia and industry.

🌟 Legacy and Future Contributions

Looking ahead, Mr. Moulick is poised to further strengthen his contributions to drug discovery and biomedical innovation. His future endeavors include completing his PhD with a high-impact third publication, finalizing his patent application, and authoring a comprehensive book chapter that can serve as a resource for young researchers and professionals.

He aims to mentor early-career scientists in preclinical research and build a legacy of scientific excellence, collaboration, and integrity. With a vision to drive innovative, affordable, and accessible therapeutics, Mr. Moulick is committed to being a catalyst for change in the Indian and global pharmaceutical landscape.

His unique blend of academic rigor, industrial experience, and collaborative mindset makes him a valuable contributor to the scientific community, and his nomination for the Best Researcher Award is both timely and well-deserved.

Publication Top Notes

Author: S., Moulick, Soumitra, D.N., Roy, Dijendra Nath

Journal: Microbial Pathogenesis

Year: 2025

Bioflavonoid Baicalein Modulates Tetracycline Resistance by Inhibiting Efflux Pump in Staphylococcus aureus

Author: Soumitra Moulick and Dijendra Nath Roy

Journal: Microbial Drug Resistance

Year: 2024